- Home
- CVAC vs NABL Comparison
CVAC vs NABL Comparison
Compare CVAC & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NABL
- Stock Information
- Founded
- CVAC 2000
- NABL 2000
- Country
- CVAC Germany
- NABL United States
- Employees
- CVAC N/A
- NABL N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NABL Computer Software: Prepackaged Software
- Sector
- CVAC Health Care
- NABL Technology
- Exchange
- CVAC Nasdaq
- NABL Nasdaq
- Market Cap
- CVAC 1.2B
- NABL 1.2B
- IPO Year
- CVAC 2020
- NABL N/A
- Fundamental
- Price
- CVAC $5.41
- NABL $8.00
- Analyst Decision
- CVAC Hold
- NABL Buy
- Analyst Count
- CVAC 3
- NABL 4
- Target Price
- CVAC $6.83
- NABL $9.38
- AVG Volume (30 Days)
- CVAC 974.1K
- NABL 1.1M
- Earning Date
- CVAC 08-14-2025
- NABL 08-07-2025
- Dividend Yield
- CVAC N/A
- NABL N/A
- EPS Growth
- CVAC N/A
- NABL N/A
- EPS
- CVAC 0.87
- NABL 0.08
- Revenue
- CVAC $566,039,775.00
- NABL $470,595,000.00
- Revenue This Year
- CVAC N/A
- NABL $8.35
- Revenue Next Year
- CVAC $24.04
- NABL $8.84
- P/E Ratio
- CVAC $6.24
- NABL $99.45
- Revenue Growth
- CVAC 787.60
- NABL 7.98
- 52 Week Low
- CVAC $2.37
- NABL $6.07
- 52 Week High
- CVAC $5.72
- NABL $14.57
- Technical
- Relative Strength Index (RSI)
- CVAC 59.79
- NABL 53.54
- Support Level
- CVAC $5.42
- NABL $7.66
- Resistance Level
- CVAC $5.49
- NABL $8.45
- Average True Range (ATR)
- CVAC 0.07
- NABL 0.21
- MACD
- CVAC -0.06
- NABL -0.01
- Stochastic Oscillator
- CVAC 36.67
- NABL 56.05
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.